Exploring MIA-QSARs' for antimalarial quinolon-4(1H)-imines

Area of Science:

• Medicinal Chemistry
• Parasitology
• Computational Chemistry

Background:

• Quinolon-4(1H)-imines represent a novel class of antimalarial compounds.
• These compounds target both exoerythrocytic and erythrocytic parasite stages, addressing clinical symptoms.
• Their inherent chemical and metabolic stability makes them promising dual-stage antimalarial drug candidates.

Purpose of the Study:

• To develop predictive quantitative structure-activity relationship (QSAR) models for antimalarial activity of quinolon-4(1H)-imines.
• To compare the predictive performance of traditional MIA-QSAR, augmented MIA-QSAR (aug-MIA-QSAR), and color-encoded aug-MIA-QSAR methods.
• To utilize QSAR descriptors for compound classification based on bioactivity levels.

Main Methods:

• Application of three multivariate image analysis applied to quantitative structure-activity relationship (MIA-QSAR) methodologies: traditional MIA-QSAR, aug-MIA-QSAR, and aug-MIA-QSARcolor.
• Development of multiple linear regression models to correlate structural descriptors with antimalarial activity.
• Utilizing discriminant analysis by partial least squares (PLS-DA) on selected aug-MIA-QSAR descriptors for pattern recognition and bioactivity classification.

Main Results:

• The augmented MIA-QSAR (aug-MIA-QSAR) method demonstrated superior predictive power and reliability compared to traditional and color-encoded versions.
• Multiple linear regression models using aug-MIA-QSAR yielded high statistical significance (R(2) = 0.8079, R(2)cv = 0.6647, R(2)pred = 0.9691).
• PLS-DA successfully classified compounds into low, moderate, and high bioactivity groups based on the identified aug-MIA-QSAR descriptors.

Conclusions:

• Augmented MIA-QSAR is a highly predictive and reliable method for modeling antimalarial activity in quinolon-4(1H)-imine series.
• The identified QSAR descriptors can effectively guide the design of new, potent dual-stage antimalarial agents.
• This study provides a robust computational framework for accelerating antimalarial drug discovery efforts.